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potentially sparing SAM for methyla  tion of 
other substrates such as As. We are currently 
testing this hypothesis in a randomized 
controlled trial of creatine supplementation. 
In addition, as Basu et al. (2011) noted, and 
as we have previously reported (Gamble and 
Liu 2005), one implication of the observed 
association between uCr and As methylation 
capacity is that urinary As should not be 
expressed per gram creatinine to correct for 
urine concentration. Rather, uCr should be 
included as a covariate in regression models. 
One concerning aspect of the study by 
Basu et al. (2011) is the handling of blood 
samples used for nutrient measure  ments. As 
noted by Basu et al. and in a previous pub‑
lication on these same participants (Chung 
et al. 2006), the blood samples were stored 
in an ice chest in the field for up to 24 hr 
before processing. This 24‑hr delay can be 
problematic for some nutrients, especially 
folate, which is extremely sensitive to oxida‑
tive degrada  tion (Drammeh et al. 2008). Basu 
et al. (2011) reported that in uni  variate analy‑
ses, they observed higher urinary percentages 
of InAs in individuals with higher serum 
folate concentrations. This finding is contrary 
to our previous findings that folate facilitates 
As methylation (Gamble et al. 2005, 2006, 
2007; Hall et al. 2007, 2009). This discrep‑
ancy might be explained by differences in 
sample processing. 
Basu et al. (2011) also reported associa‑
tions between dietary intake of several nutri‑
ents (assessed using a modified 24‑hr recall) 
and As methylation capacity. One of the most 
critical and widely discussed issues in nutri‑
tional epidemiology is the method used to 
adjust for total energy intake (TEI) (Willett 
et al. 1997). The main reasons to adjust for 
TEI are to a) adjust for potential confound‑
ing by TEI, b) remove extraneous variation 
in nutrient intakes that is due only to their 
correlation with TEI, and c) simulate a dietary 
intervention. What is often most relevant is 
diet composition, or nutrient intake in rela‑
tion to TEI (Willett et al. 1997). Several 
methods are available to adjust for TEI, and 
the best approach can vary depending on 
the nutrient and question of interest. Basu 
et al. (2011) adjusted for TEI by dividing 
each nutrient intake by TEI (nutrient density 
method). While this approach is appealing 
because of its simplicity, in reality it can cre‑
ate a complex variable (Willett and Stampfer 
1998). For example, when TEI is related 
to the outcome of interest, the use of nutri‑
ent densities can actually induce confound‑
ing in the opposite direction. Although we 
cannot determine from Basu et al.’s article 
whether TEI measured by the 24‑hr recall 
was associated with As methylation, in theory, 
an association seems plausible. Also, because 
their statistical analy  sis tested for associations 
between multiple nutrients and urinary As 
metabolites, it is best to acknowledge that 
some of the statistically significant associations 
might be due to chance alone.
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We thank Hall and Gamble for their interest 
in our findings. In our article (Basu et al. 
2011), we cited their earlier results concerning 
urinary dimethylarsinic acid (DMA) and 
creati  nine concentrations, noting that in 2005 
they reported a strong correlation between 
urinary creatinine and the percentage of DMA 
(DMA%) (Gamble et al. 2005). We also 
noted rather similar findings from another 
group working in Bangladesh (Nermell et al. 
2008), so together with our findings in India, 
there are three separate studies that have 
reported this association (Basu et al. 2011; 
Gamble et al 2005; Nermell et al 2008). 
Our results highlight the strength of the 
relation  ship between urinary creatinine and 
urinary DMA%, which was stronger than 
the relationship between DMA% and any of 
the 19 dietary factors and 16 blood micro‑
nutrients that we investigated.
Gamble and Hall state that they had pre‑
viously reported (Gamble and Liu 2005) 
that one implication of the observed asso‑
ciation between urinary creatinine and arse‑
nic methyla  tion was that urinary As should 
not be expressed as per gram creatinine to 
correct for urine concentrations. This is 
not quite what they said, although they did 
point out risks in expressing urinary arsenic 
per gram of creatinine. However, in that 
letter (Gamble and Liu 2005) and again in 
this one, they state that urinary creatinine 
should be included as a covariate in regres‑
sion models. We do not agree with this 
recom  mendation. Steinmaus et al. (2009) 
reported a spurious relation  ship between 
low‑level arsenic concentrations and diabetes 
in the United States after including urinary 
creatinine in a regression model. They noted 
that urinary creatinine concentrations may 
change as a consequence of diabetes, which 
is known to affect renal function, and that it 
is not appropriate to adjust for a factor that 
is a consequence of the disease being studied. 
We also do not agree with Gamble and 
Hall’s criticism of our blood sample handling, 
which they appear to have raised because our 
folate findings were different from theirs (e.g., 
Gamble et al. 2005). For our study (Basu 
et al. 2011), blood samples were collected in 
remote villages, and on occasion they had to 
be stored on ice for up to 24 hr. Gamble and 
Hall state that “this 24‑hr delay can be prob‑
lematic for some nutrients, especially folate, 
which is extremely sensitive to oxidative 
degradation.” In support of this statement 
they cite Drammeh et al. (2008), who found 
reductions in serum folate concentrations Correspondence
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(about 30%) from whole blood stored for 
1 day at 32°C. However, storing blood sam‑
ples on ice at about 0°C is not the same as 
storing at 32°C, so this result is not relevant. 
In addition, Drammeh et al. cited a study 
that reported stable plasma folate levels dur‑
ing storage of up to 7 days at 4°C (Kubasik 
et al. 1979). We therefore do not think our 
findings should be criticized based on sample 
storage.
However, this does not mean we suggest 
that folate is not related to DMA%. Findings 
may vary from study to study, and we accept 
that Gamble et al. have reported several 
studies suggesting that folate is associated 
with small increases in arsenic methylation, 
including a randomized trial with folate sup‑
plements (Gamble et al. 2006). In a study of 
pregnant women in Bangladesh, a small asso‑
ciation between folate and arsenic methyla‑
tion was reported (Gardner et al. 2011; Li 
et al. 2008); the authors concluded that 
nutritional status has a marginal influence 
on the metabolism of arsenic in pregnant 
women. Although the overall evidence sug‑
gests that folate may increase arsenic methyla‑
tion, the magnitude of the effect is small and 
in our opinion of little consequence.
In their letter Gamble et al. report they 
are now conducting a randomized trial with 
creatine. Well‑run randomized trials of nutri‑
tional supplements with sufficient statistical 
power typically require a large amount of 
public health funds and resources. We suggest 
that randomized trials should be conducted 
only on people whose exposure to arsenic has 
ceased. However, it is clear that exposures 
did not cease in the randomized trial of folate 
they conducted, but that exposures remained 
markedly elevated based on urine arsenic con‑
centrations (Gamble et al. 2006). The purpose 
of a randomized trial of folate or creatine is to 
determine whether these agents might affect 
arsenic methylation to help reduce arsenic 
toxicity and increase excretion. However, the 
relevance of this goal is questionable because 
we already know the best and most appropri‑
ate way to reduce arsenic toxicity—by reduc‑
ing exposure. The first priority should be to 
stop exposure to arsenic. If exposure to arsenic 
ceased, there would be very little arsenic to 
methylate and enhancement of methylation 
with supplements would not be necessary.
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